In a startling pandemic preparedness development, Moderna yesterday announced that US Department of Health and Human Services ...

Neutralizing antibodies tested 90 days after infection were greater in participants who had been vaccinated before their ...

A new Annenberg Poll shows that 87% of Americans say the benefit of childhood measles, mumps, and rubella (MMR) vaccination ...

A survey of Medicare-certified home healthcare (HHC) agencies reveals minor improvements and problematic declines in ...

The US Centers for Disease Control and Prevention (CDC) in its weekly update today reported 42 measles cases, some tied to a ...

The World Health Organization (WHO) today posted an outbreak notice about a rise in COVID activity in three of its regions, ...

Long-COVID symptoms were based on caregiver-reported symptoms lasting at least 90 days after COVID infections; in total 41 ...

The data show a continuation of a decades-old trend toward increasing US excess deaths, mainly among working-age adults, ...

Drug makers Spero Therapeutics and GSK announced yesterday that a phase 3 trial evaluating their investigational oral ...

Cambodia's ministry of health has reported its fourth fatal human H5N1 avian flu case of the year, which involves an ...

Surveillance identified 7,381 candidemia cases, with an incidence of 7.4 cases per 100,000 people. Across age-groups, sexes, ...

Today vaccine maker Moderna announced it voluntarily pulled its licensing submission for the combination seasonal ...